SIGA Technologies Inc

Research SIGA Technologies Inc (SIGA) on Bullrun: valuation model: 12.9% undervalued, market cap USD 258.92M, P/E 12.8, dividend yield 16.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSIGA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Valuation signal12.9% undervalued
• Market capUSD 258.92M
• P/E12.8
• Dividend yield16.6%
• Financial periodFY2025
• RevenueUSD 94.57M
• Revenue growth-31.8%
• Net incomeUSD 23.28M
• Gross margin68.6%

Valuation Snapshot

Bullrun's latest valuation model marks SIGA Technologies Inc as 12.9% undervalued; latest market cap is USD 258.92M; P/E is 12.8; dividend yield is 16.6%.

About SIGA Technologies Inc

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.

Frequently asked questions

Is SIGA Technologies Inc overvalued or undervalued?

Bullrun's valuation model currently marks SIGA Technologies Inc as 12.9% undervalued.

What is SIGA Technologies Inc's market cap?

SIGA Technologies Inc's market capitalization is USD 258.92M.

What is SIGA Technologies Inc's P/E ratio?

SIGA Technologies Inc's price-to-earnings (P/E) ratio is 12.8.

Does SIGA Technologies Inc pay a dividend?

SIGA Technologies Inc has a dividend yield of 16.6%.

What does SIGA Technologies Inc do?

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc.